Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Granules India stock

GRANULES.NS
INE101D01020

Price

508.55
Today +/-
-0.20
Today %
-3.57 %

Granules India stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Granules India stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Granules India stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Granules India stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Granules India's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Granules India Stock Price History

DateGranules India Price
2/21/2025508.55 undefined
2/20/2025527.05 undefined
2/19/2025531.45 undefined
2/18/2025518.75 undefined
2/17/2025522.25 undefined
2/14/2025512.85 undefined
2/13/2025542.25 undefined
2/12/2025538.10 undefined
2/11/2025552.20 undefined
2/10/2025569.05 undefined
2/7/2025582.90 undefined
2/6/2025578.90 undefined
2/5/2025582.70 undefined
2/4/2025570.90 undefined
2/3/2025556.45 undefined
2/1/2025566.00 undefined
1/31/2025556.35 undefined
1/30/2025564.45 undefined
1/29/2025536.00 undefined
1/28/2025516.40 undefined
1/27/2025544.60 undefined

Granules India Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Granules India, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Granules India from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Granules India’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Granules India. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Granules India’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Granules India’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Granules India’s growth potential.

Granules India Revenue, EBIT and net profit per share

DateGranules India RevenueGranules India EBITGranules India Net Income
2027e61.13 B undefined11.3 B undefined8.2 B undefined
2026e52.74 B undefined9.07 B undefined6.51 B undefined
2025e46.3 B undefined7.61 B undefined4.95 B undefined
202445.06 B undefined6.53 B undefined4.05 B undefined
202345.12 B undefined7.38 B undefined5.17 B undefined
202237.65 B undefined5.75 B undefined4.13 B undefined
202132.38 B undefined7.13 B undefined5.5 B undefined
202025.99 B undefined4.22 B undefined3.35 B undefined
201922.79 B undefined2.79 B undefined2.36 B undefined
201816.92 B undefined2.02 B undefined1.33 B undefined
201714.35 B undefined2.33 B undefined1.65 B undefined
201613.83 B undefined2.18 B undefined1.23 B undefined
201512.93 B undefined1.56 B undefined909 M undefined
201410.96 B undefined1.29 B undefined752 M undefined
20137.64 B undefined626 M undefined326 M undefined
20126.54 B undefined586 M undefined300 M undefined
20114.75 B undefined384 M undefined209 M undefined
20104.61 B undefined429 M undefined304 M undefined
20092.89 B undefined310 M undefined42 M undefined
20082.57 B undefined245 M undefined90 M undefined
20071.88 B undefined210 M undefined76 M undefined
20061.79 B undefined194 M undefined74 M undefined
20051.37 B undefined156 M undefined58 M undefined

Granules India Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
2004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
1.191.371.791.882.572.894.614.756.547.6410.9612.9313.8314.3516.9222.7925.9932.3837.6545.1245.0646.352.7461.13
-15.2631.025.0336.4212.7459.383.0637.6316.8843.3717.986.963.7917.8734.7214.0124.5916.2919.84-0.122.7513.8915.91
27.8226.4826.6334.0827.0827.7626.1536.9736.2738.5440.0340.8244.7950.0545.5544.1349.8855.7648.6045.5851.2049.8343.7537.74
0.330.360.480.640.70.81.211.762.372.954.395.286.197.187.7110.0612.9618.0518.320.5623.07000
0.040.060.070.080.090.040.30.210.30.330.750.911.231.651.332.363.355.54.135.174.054.956.518.2
-48.7227.592.7018.42-53.33623.81-31.2543.548.67130.6720.8835.3133.74-19.3978.2841.8863.83-24.8825.12-21.5322.1631.5325.92
------------------------
------------------------
79101137149216201201202201206206206211220242255255250249245.74242.35000
------------------------
Details

Keystats

Revenue and Growth

The Granules India Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Granules India is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (B)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (B)INTANGIBLE ASSETS (B)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (B)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                         
0.040.230.060.360.050.060.040.050.230.100.471.240.421.080.822.382.622.912.923.81
0.240.360.240.370.380.630.660.720.950.711.113.573.754.186.286.746.627.659.259.499.87
0.090.090.090.150.160.160.160.070.090.010.140.010.080.350.410.270.390.450.281.041.46
0.210.270.350.30.530.60.690.751.11.371.742.092.542.693.024.124.698.2110.1211.7113.55
00.010.010.020.090.130.190.20.240.710.770.520.560.641.070.882.221.042.490.580.37
0.580.960.751.21.211.571.741.792.62.893.776.668.188.2811.8712.8216.2919.9725.0525.7429.05
0.570.861.281.772.222.212.182.252.633.594.994.75.546.999.9110.7111.3712.5615.9618.5921.16
000000000000.670.71.081.572.10.190.190.320.210.22
00000000.110.280.1300.220.380.310.360.460.771.260.771.431.73
0.030.040.150.320.270.240.210.210.170.131.080.870.832.1333.693.613.153.022.912.52
000000000000000000000
102132223120203368275000704253814162.77538.07
0.610.921.462.112.522.472.422.573.113.946.156.467.4510.5114.9117.011617.1720.0823.326.16
1.191.892.213.313.734.054.164.365.716.839.9213.1215.6318.7926.7729.8332.2837.1345.1349.0555.21
                                         
83123124202202217217201201201203204217229254254254248248242.04242.37
0.070.430.441.191.191.181.181.181.181.181.191.22.253.346.246.256.254.534.561.491.52
0.140.180.230.280.340.350.630.821.071.352.152.94.155.456.488.5411.5916.8420.5925.5729.24
0000000000.010.01000.020.060.250.340.120.471.051.25
630000000000000000000
0.290.730.81.671.741.752.022.22.452.753.564.316.629.0413.0415.318.4421.7325.8728.3532.26
000000.280.380.520.760.921.361.831.812.162.743.243.575.416.397.827.5
00000412687184093152128174193393404512.09706.12
175178260207432581055121818322713972237455432467846983631.78992.6
00000000.831.020.861.013.313.934.745.254.543.724.097.668.1110.54
00000000.160.140.10.320.540.640.580.20.580.990.990.991.061.09
0.180.180.260.210.430.340.491.572.142.062.935.866.557.878.788.978.9411.7316.4218.1420.82
0.70.941.081.341.451.831.470.380.881.763.092.431.841.244.334.794.223.412.422.191.52
263971921131231751992302453034815685655436554821113976.52230.96
00000001215204043567277126215248283292.56378.8
0.730.981.151.431.561.961.640.591.132.023.442.952.471.884.955.574.913.672.842.562.13
0.91.161.411.641.992.32.142.163.264.086.368.819.019.7513.7314.5313.8515.419.2620.722.95
1.21.892.213.313.734.054.164.365.716.839.9213.1215.6318.7926.7729.8332.2837.1345.1249.0555.21
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Granules India provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Granules India's financial health and stability.

Assets

Granules India's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Granules India must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Granules India after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Granules India's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (B)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (B)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20042005200620072008200920102011201220132014201520162017201820192020202120222023
0.070.070.090.110.130.070.380.270.430.461.121.281.862.051.82.774.267.045.586.87
0.030.030.050.080.120.120.190.180.210.230.30.530.580.720.761.051.371.511.591.84
00000000000000000000
-300-280-198-332-179-434-28-113-55134-548-630-1,272-1,119-2,881-1,643-1,063-4,663-4,022-1,861
81748910311312363148170183205327342236312443199429176531
777589102106125144131167177205318372318314277266262241532
0.020.01000.010.010.060.060.120.110.240.320.480.60.580.881.191.911.451.76
-0.12-0.10.04-0.040.18-0.120.60.490.260.911.081.51.511.88-0.012.624.764.323.327.39
-246-335-556-744-540-93-127-249-550-1,164-2,667-1,480-1,622-3,166-4,464-2,794-1,844-2,713-3,977-4,106
-243-344-553-744-544-88-133-250-544-1,277-2,546-1,455-1,616-3,260-4,623-2,698-1,606-2,771-3,801-1,913
0-0.0100-00-0.01-00.01-0.110.120.030.01-0.09-0.160.10.24-0.060.182.19
00000000000000000000
0.350.240.330.250.110.39-0.28-0.090.690.681.710.580.130.272.960.4-1.56-0.752.48-0.6
0.040.40.010.83000000.010.010.011.330.832.930.010-1.730.04-3.08
0.380.640.351.090.110.23-0.46-0.250.490.461.470.190.860.565.29-0.17-2.13-2.991.9-4.4
------125.00-144.00-131.00-167.00-177.00-205.00-318.00-372.00-318.00-314.00-277.00-266.00-262.00-241.00-537.00
00000-28-29-29-34-46-47-83-234-223-290-306-306-247-371-186
0.020.19-0.170.3-0.260.020.01-0.010.20.100.240.75-0.820.66-0.251.03-1.441.431.07
-366.4-435-518.1-781.1-364.5-216469.4236-294.2-252.7-1,587.822-107.7-1,283.7-4,470.9-171.62,917.11,611.4-656.63,280.72
00000000000000000000

Granules India stock margins

The Granules India margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Granules India. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Granules India.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Granules India's sales revenue. A higher gross margin percentage indicates that the Granules India retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Granules India's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Granules India's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Granules India's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Granules India. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Granules India's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Granules India Margin History

Granules India Gross marginGranules India Profit marginGranules India EBIT marginGranules India Profit margin
2027e51.2 %18.49 %13.42 %
2026e51.2 %17.2 %12.35 %
2025e51.2 %16.43 %10.69 %
202451.2 %14.49 %8.99 %
202345.58 %16.35 %11.45 %
202248.6 %15.27 %10.96 %
202155.76 %22.03 %16.97 %
202049.88 %16.23 %12.91 %
201944.13 %12.24 %10.37 %
201845.55 %11.96 %7.84 %
201750.05 %16.23 %11.46 %
201644.79 %15.74 %8.89 %
201540.82 %12.07 %7.03 %
201440.03 %11.75 %6.86 %
201338.54 %8.19 %4.26 %
201236.27 %8.96 %4.59 %
201136.97 %8.08 %4.4 %
201026.15 %9.3 %6.59 %
200927.76 %10.72 %1.45 %
200827.08 %9.55 %3.51 %
200734.08 %11.16 %4.04 %
200626.63 %10.83 %4.13 %
200526.48 %11.41 %4.24 %

Granules India Stock Sales Revenue, EBIT, Earnings per Share

The Granules India earnings per share therefore indicates how much revenue Granules India has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Granules India earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Granules India's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Granules India’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Granules India's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Granules India Revenue, EBIT and net profit per share

DateGranules India Sales per ShareGranules India EBIT per shareGranules India Earnings per Share
2027e252.08 undefined0 undefined33.82 undefined
2026e217.48 undefined0 undefined26.86 undefined
2025e190.95 undefined0 undefined20.42 undefined
2024185.94 undefined26.94 undefined16.72 undefined
2023183.61 undefined30.02 undefined21.02 undefined
2022151.2 undefined23.09 undefined16.58 undefined
2021129.5 undefined28.52 undefined21.98 undefined
2020101.91 undefined16.54 undefined13.15 undefined
201989.38 undefined10.94 undefined9.27 undefined
201869.91 undefined8.36 undefined5.48 undefined
201765.24 undefined10.59 undefined7.48 undefined
201665.54 undefined10.31 undefined5.83 undefined
201562.76 undefined7.58 undefined4.41 undefined
201453.2 undefined6.25 undefined3.65 undefined
201337.11 undefined3.04 undefined1.58 undefined
201232.54 undefined2.92 undefined1.49 undefined
201123.52 undefined1.9 undefined1.03 undefined
201022.94 undefined2.13 undefined1.51 undefined
200914.39 undefined1.54 undefined0.21 undefined
200811.88 undefined1.13 undefined0.42 undefined
200712.62 undefined1.41 undefined0.51 undefined
200613.07 undefined1.42 undefined0.54 undefined
200513.53 undefined1.54 undefined0.57 undefined

Granules India business model

Granules India Ltd is a registered company in Hyderabad, India, specializing in the manufacturing of pharmaceutical active ingredients and formulations, product development, biotechnology research, and diagnostics. The company was established in 1984 and has become one of the leading suppliers of pharmaceutical active ingredients. The origins of Granules India Ltd began as a small company with only a few employees. In 1991, the company started production of Allantoin, a cosmetic active ingredient. Over the years, the company steadily grew and expanded its production capacities. In 1995, Granules India Ltd began manufacturing pharmaceutical active ingredients as part of its business. In the late 90s, the company expanded into other countries to distribute its products worldwide. Today, the main markets for Granules India Ltd are India, North America, Europe, and Asia. The company also has distribution offices in the USA, Europe, and Asia. Granules India Ltd has divided its business model into three main sectors: 1. Pharmaceutical Active Ingredients (APIs) - Granules India Ltd specializes in the manufacturing of pharmaceutical active ingredients used in drug production. The company produces a wide range of APIs, including Paracetamol, Ibuprofen, Metformin, and more. 2. Formulations - Granules India Ltd also produces various pharmaceutical formulations such as tablets, capsules, suspensions, and more. The company is able to develop and manufacture customized formulations according to customer requirements. 3. Biologics - In recent years, the company has also invested in biotechnology research, particularly in the development and manufacturing processes of biologics such as antibody drugs. The field of diagnostics is also covered. Granules India Ltd has established a strong position as a manufacturer of pharmaceutical active ingredients in recent years. The company supplies many of the major pharmaceutical companies worldwide. It has six production facilities in India that manufacture pharmaceutical active ingredients and formulations. The company also supplies to other manufacturers to support their production processes. In terms of products, Granules India Ltd offers a wide range of pharmaceutical active ingredients and formulations, all manufactured to the highest quality and in compliance with international standards. Some of the company's most well-known products are Paracetamol, Ibuprofen, Metformin, and Tramadol, used in pain management. The wide range of formulations includes tablets, capsules, suspensions, and more, used in various therapy areas such as cardiology, oncology, neurology, and infectious diseases. Overall, Granules India Ltd has achieved a leading position in the market for pharmaceutical active ingredients and formulations. The company has invested in research and development in recent years to expand its product range and provide customized solutions. Granules India Ltd remains committed to meeting the high standards in the pharmaceutical industry and developing innovative products to meet the needs of its customers. Granules India is one of the most popular companies on Eulerpool.com.

Granules India SWOT Analysis

Strengths

Granules India Ltd has a strong presence in the pharmaceutical industry.

The company has a diverse portfolio of products.

Granules India Ltd has established strong relationships with clients, suppliers, and distributors.

Weaknesses

The company may face challenges in maintaining consistent quality across its product range.

Granules India Ltd relies heavily on third-party suppliers for raw materials, which poses a risk to its supply chain.

Opportunities

The growing demand for generic drugs presents a significant opportunity for Granules India Ltd to expand its market share.

Expansion into new geographic markets can help the company diversify its revenue streams.

Increasing investments in research and development can enable Granules India Ltd to develop innovative products.

Threats

Intense competition within the pharmaceutical industry may impact Granules India Ltd's market position.

Changes in government regulations and policies can pose a threat to the company's operations.

Economic downturns or fluctuations in currency exchange rates can affect Granules India Ltd's financial performance.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Granules India Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Granules India historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Granules India shares outstanding

The number of shares was Granules India in 2024 — This indicates how many shares 242.35 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Granules India earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Granules India's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Granules India’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Granules India's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Granules India stock splits

In Granules India's history, there have been no stock splits.

Granules India dividend history and estimates

In 2024, Granules India paid a dividend amounting to 1.5 INR. Dividend means that Granules India distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Granules India provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Granules India’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Granules India's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Granules India Dividend History

DateGranules India Dividend
2027e1.72 undefined
2026e1.72 undefined
2025e1.72 undefined
20241.5 undefined
20231.5 undefined
20221 undefined
20211.5 undefined
20201 undefined
20191 undefined
20181 undefined
20171 undefined
20160.75 undefined
20150.65 undefined
20140.35 undefined
20130.2 undefined
20120.2 undefined
20110.15 undefined
20100.13 undefined
20090.13 undefined
20080.13 undefined

Granules India dividend payout ratio

In 2024, Granules India had a payout ratio of 6.56%. The payout ratio indicates the percentage of the company's profits that Granules India distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Granules India represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Granules India could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Granules India's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Granules India Payout Ratio History

DateGranules India Payout ratio
2027e6.55 %
2026e6.62 %
2025e6.47 %
20246.56 %
20236.82 %
20226.04 %
20216.82 %
20207.6 %
201910.78 %
201818.28 %
201713.37 %
201612.86 %
201514.74 %
20149.59 %
201312.66 %
201213.42 %
201114.42 %
20108.28 %
200959.52 %
200829.76 %
20076.82 %
20066.82 %
20056.82 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Granules India.

Granules India latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20245.15 4.85  (-5.83 %)2025 Q3
3/31/20215.05 5.13  (1.64 %)2021 Q4
12/31/20205.36 5.9  (10.16 %)2021 Q3
6/30/20201.85 4.36  (135.17 %)2021 Q1
3/31/20202.54 1.28  (-49.62 %)2020 Q4
12/31/20193.22 2.51  (-22.02 %)2020 Q3
9/30/20192.67 3.76  (40.81 %)2020 Q2
6/30/20192.53 3.27  (29.32 %)2020 Q1
3/31/20192.44 2.51  (2.71 %)2019 Q4
12/31/20182.2 2.36  (7.07 %)2019 Q3
1
2
3

Eulerpool ESG Scorecard© for the Granules India stock

Eulerpool World ESG Rating (EESG©)

55/ 100

🌱 Environment

56

👫 Social

56

🏛️ Governance

53

Environment

Scope 1 - Direct Emissions
56,265
Scope 2 - Indirect emissions from purchased energy
56,306
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
112,571
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees6.575
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Granules India shareholders

%
Name
Stocks
Change
Date
31.67104 % Chigurupati (Krishna Prasad)76,799,11109/30/2024
4.25603 % Life Insurance Corporation of India10,320,4551,852,4109/30/2024
3.81078 % Chigurupati (Uma Devi)9,240,76109/30/2024
2.78998 % Axis Asset Management Company Limited6,765,433405,4819/30/2024
2.20128 % Quant Money Managers Ltd5,337,89406/30/2024
1.82998 % FIL Investment Management (Singapore) Ltd.4,437,529-4,272,2119/30/2024
1.72038 % The Vanguard Group, Inc.4,171,75832,0179/30/2024
1.71824 % Schroder Investment Management Ltd. (SIM)4,166,55107/31/2024
1.59969 % Dimensional Fund Advisors, L.P.3,879,08509/30/2024
1.46503 % Tyche Investments Pvt. Ltd.3,552,55709/30/2024
1
2
3
4
5
...
10

Granules India Executives and Management Board

Dr. Krishna Chigurupati

(67)
Granules India Executive Chairman of the Board, Managing Director (since 2014)
Compensation 353.56 M

Dr. Kandiraju Rao

Granules India Chief Executive Officer, Joint Managing Director, Executive Director (since 2022)
Compensation 94.56 M

Mr. Harsha Chigurupati

(39)
Granules India Non-Independent Executive Director (since 2010)
Compensation 35.36 M

Mrs. Uma Chigurupati

(63)
Granules India Non-Independent Executive Director (since 2012)
Compensation 35.36 M

Ms. Chaitanya Tummala

Granules India Compliance Officer, Company Secretary
Compensation 7.89 M
1
2
3
4

Most common questions regarding Granules India

What values and corporate philosophy does Granules India represent?

Granules India Ltd represents values of integrity, quality, and patient-centricity. With a corporate philosophy focused on innovation and customer satisfaction, the company strives to provide cost-effective and high-quality pharmaceutical products. Granules India Ltd emphasizes on continuous improvement, ethical business practices, and delivering value to all stakeholders. The company's commitment to research, development, and regulatory compliance highlights its dedication to providing safe and effective healthcare solutions. Through its customer-centric approach and consistent growth, Granules India Ltd has established itself as a leading player in the pharmaceutical industry.

In which countries and regions is Granules India primarily present?

Granules India Ltd is primarily present in India, as it is an Indian pharmaceutical company. It has established a strong presence in the domestic market and has been serving the healthcare needs of millions of people in the country. With its state-of-the-art manufacturing facilities located across various regions in India, Granules India Ltd has successfully catered to the growing demand for high-quality pharmaceutical products. Additionally, the company has also expanded its global footprint and has a significant presence in several countries worldwide, including the United States, Europe, and Asia, through its diverse customer base and strategic partnerships.

What significant milestones has the company Granules India achieved?

Granules India Ltd has achieved several significant milestones in its journey. The company has successfully established itself as a leading manufacturer of pharmaceutical formulation intermediates (PFIs) and active pharmaceutical ingredients (APIs). With a focus on innovation and quality, Granules India Ltd has received multiple certifications, including EU GMP and US FDA approvals for its manufacturing units. The company has also expanded its presence globally, with a strong customer base across various countries. Additionally, Granules India Ltd has consistently shown robust financial performance, with steady revenue growth and improved profitability. These achievements highlight the company's commitment to excellence and make it a trusted name in the pharmaceutical industry.

What is the history and background of the company Granules India?

Granules India Ltd is a leading pharmaceutical company that specializes in the manufacturing and marketing of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages (FDs). Established in 1984, Granules India Ltd has grown exponentially over the years and is now recognized as one of India's largest vertically integrated pharmaceutical manufacturers. With a strong focus on research and development, Granules India Ltd has successfully developed and commercialized numerous products for various therapeutic segments. The company's commitment to quality, innovation, and customer satisfaction has positioned it as a trusted global player in the pharmaceutical industry. Granules India Ltd continues to expand its product portfolio and strengthen its presence in both domestic and international markets.

Who are the main competitors of Granules India in the market?

The main competitors of Granules India Ltd in the market include Aurobindo Pharma Ltd, Divis Laboratories Ltd, and Dr. Reddy's Laboratories Ltd.

In which industries is Granules India primarily active?

Granules India Ltd is primarily active in the pharmaceutical industry. With its focus on manufacturing and exporting pharmaceutical products, the company plays a crucial role in the healthcare sector. Granules India Ltd has established itself as a leading player in the global pharmaceutical market, providing high-quality active pharmaceutical ingredients (APIs), intermediates, and finished dosages to customers worldwide. The company's commitment to innovation, quality, and customer satisfaction has contributed to its success and growth in the highly competitive pharmaceutical industry. Granules India Ltd continuously strives to meet the healthcare needs of patients by providing affordable and effective medicines.

What is the business model of Granules India?

Granules India Ltd operates under a business model that focuses on pharmaceutical manufacturing. The company specializes in the production and distribution of active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). With an extensive portfolio of products, Granules India Ltd caters to both domestic and international markets. By leveraging their strong research and development capabilities, the company ensures the highest quality standards in drug manufacturing. Granules India Ltd's commitment to innovation and customer-centric approach has established them as a leading player in the pharmaceutical industry.

What is the P/E ratio of Granules India 2025?

The Granules India P/E ratio is 24.89.

What is the P/S ratio of Granules India 2025?

The Granules India P/S ratio is 2.66.

What is the Quality Investing of Granules India?

The Quality Investing for Granules India is 7/10.

What is the revenue of Granules India 2025?

The expected Granules India revenue is 46.3 B INR.

How high is the profit of Granules India 2025?

The expected Granules India profit is 4.95 B INR.

What is the business model of Granules India

Granules India Ltd is a leading company in the pharmaceutical active ingredient and formulation industry, headquartered in Hyderabad, India. It started as a small company in 1984 and has grown into a multinational company operating in over 60 countries. The business areas of Granules India include pharmaceutical active ingredients, dosage forms, research and development, as well as equipment and supplies. The company is a major player in the manufacturing of generic drugs, which provide a cost-effective alternative to more expensive patented medications. Pharmaceutical active ingredients: Granules India produces a wide range of pharmaceutical active ingredients used in various medical applications, including pain management, metabolic disorders, cardiovascular and infectious diseases. The company has a strong expertise in manufacturing active ingredients for novel drugs and offers a wide range of products in different therapy areas. Dosage forms: The company also produces a variety of dosage forms such as tablets, capsules, granules, and powders, which allow for the delivery of active ingredients in the desired quantity and dosage to the patient. Granules India works closely with its customers to develop customized solutions for their specific requirements. Research and development: Granules India maintains an extensive research and development department specializing in the development and manufacturing of novel active ingredients and formulations. The company is committed to seeking new technologies and techniques to produce better pharmaceutical products that are more effective and safer. Equipment and supplies: Granules India also has a department for equipment and supplies that support the manufacturing of pharmaceutical products. They manufacture machines and equipment used by other pharmaceutical companies to produce their products. They also offer specialized services such as installation, maintenance, and repair of these equipment. Granules India is also a key player in the development of biosimilars approved by the Food and Drug Administration (FDA). The company also develops and manufactures topical medications such as ointments, gels, and creams, which treat skin issues and infections. Overall, Granules India has an impressive business model and offers a wide range of pharmaceutical products and services. The company has focused on quality, collaboration, and innovation, and is able to provide tailored solutions to its customers' specific needs.

What is the Granules India dividend?

Granules India pays a dividend of 1 INR distributed over payouts per year.

How often does Granules India pay dividends?

The dividend cannot currently be calculated for Granules India or the company does not pay out a dividend.

What is the Granules India ISIN?

The ISIN of Granules India is INE101D01020.

What is the Granules India ticker?

The ticker of Granules India is GRANULES.NS.

How much dividend does Granules India pay?

Over the past 12 months, Granules India paid a dividend of 1.5 INR . This corresponds to a dividend yield of about 0.29 %. For the coming 12 months, Granules India is expected to pay a dividend of 1.72 INR.

What is the dividend yield of Granules India?

The current dividend yield of Granules India is 0.29 %.

When does Granules India pay dividends?

Granules India pays a quarterly dividend. This is distributed in the months of March, August, September, August.

How secure is the dividend of Granules India?

Granules India paid dividends every year for the past 20 years.

What is the dividend of Granules India?

For the upcoming 12 months, dividends amounting to 1.72 INR are expected. This corresponds to a dividend yield of 0.34 %.

In which sector is Granules India located?

Granules India is assigned to the 'Health' sector.

Wann musste ich die Aktien von Granules India kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Granules India from 8/1/2024 amounting to 1.5 INR, you needed to have the stock in your portfolio before the ex-date on 7/30/2024.

When did Granules India pay the last dividend?

The last dividend was paid out on 8/1/2024.

What was the dividend of Granules India in the year 2024?

In the year 2024, Granules India distributed 1.5 INR as dividends.

In which currency does Granules India pay out the dividend?

The dividends of Granules India are distributed in INR.

All fundamentals about Granules India

Our stock analysis for Granules India Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Granules India Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.